Sunday, 21 June 2015

WEEKLY SUPPORT & REISTANCE OF NIFTY & SENSEX




INDEX                                S3          S2          S1         PIVOT       R1          R2          R3
NIFTY (8225)                    7723      7834     8029        8140         8335       864          8641

SENSEX  (27316)              24850     25579    25947     26676       27044    27773     28141



WEEKLY GLOBAL STOCK  MARKET  INDEX POSITION
INDEXES

POSITIONS


CURRENT
(20/06/15)
WEEK  AGO
(14/06/15)
CHANGE %
BUY
/SELL
SENSEX
27316.17
26768.49
+2.05%
BUY
NIFTY
8224.94
7982.9
+3.03%
BUY
NASDAQ
5117.00
5051.1
+1.3%
STRONG
BUY
S&P 500
2109.75
2094.11
+0.75%
STRONG
BUY
ASIA MARKET
NIKKEI
20174.24
20407.08
-1.14%
STRONG
BUY
HANG SENG
26760.53
27280.54
-1.91%
BUY
EUROPE MARKET
FTSE100
6710.45
8784.94
-1.1%
SELL
DAX
11196.49
11040.4
-3.4%
STRONG
SELL
CAC40
4815.37
4901.19
-1.79%
NEUTRAL






BROKER'S RECOMMENDATIONS ON LAST WEEK
COMPANY
TIPS/RECOM DATE
TARGET
REOM. PRICE
TIME FRAME
BROKER/ANALYST
RALLIS INDIA
BUY/19-06-15
280
235-241
1/2 YEAR
ICICI SECURITIES
M&M FINNANCIAL SERVICES
BUY/19-06-15
320
255
1 YEAR
KOTAK SECURITIES
NALCO
BUY/17-06-15
57
41.2
1 YEAR
CREDIT SUISSE
INSECTICIDES
BUY/15-06-15
800
510
1 YEAR
MOTILAL OSWAL


 WEEKLY NEWS FLASH

  
Ø  Biocon’s research arm Syngene International received capital markets regulator's approval to launch an initial public offer.

Ø  Larsen & Toubro’s construction unit won orders worth Rs 2278 crore across various business segments in May and June 2015

Ø  BHEL has commissioned NTPC’s 800 MW Koldam hydro power project in Mandi district of Himachal Pradesh

Ø  Larsen & Toubro’s construction unit won orders worth Rs 2278 crore across various business segments in May and June 2015.

Ø  Yes Bank cut its base rate by 25 basis points from 10.75% per annum to 10.50% per annum, effective from 22 June 2015

Ø  Unions have suspended next week's planned strike action at Tata Steel's UK plants and are recommending that their members accept the company's new pension offer
Ø  Glenmark Pharmaceuticals has received the final nod from the US health regulator for generic oral contraceptive Levonorg-estrel/ Ethinyl Estradiol tablets and plans to commence shipping of the product immediately